Patents by Inventor Dimple CHAKRAVARTY

Dimple CHAKRAVARTY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEAT1 as a prognostic marker and therapeutic target for prostate cancer
    Patent number: 10294476
    Abstract: This invention relates to diagnosis and prognosis of prostate cancer, as well as therapeutic treatment of prostate cancer. More specifically, the invention provides diagnostic and prognostic methods based on detecting nuclear enriched abundant transcript 1 (NEAT1) levels in a sample. Further provided are methods for treating prostate cancer based on targeting NEAT1 via interfering RNA.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: May 21, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Dimple Chakravarty, Mark A. Rubin
  • NEAT1 AS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET FOR PROSTATE CANCER
    Publication number: 20170037408
    Abstract: This invention relates to diagnosis and prognosis of prostate cancer, as well as therapeutic treatment of prostate cancer. More specifically, the invention provides diagnostic and prognostic methods based on detecting nuclear enriched abundant transcript 1 (NEAT1) levels in a sample. Further provided are methods for treating prostate cancer based on targeting NEAT1 via interfering RNA.
    Type: Application
    Filed: April 17, 2015
    Publication date: February 9, 2017
    Applicant: CORNELL UNIVERSITY
    Inventors: Dimple CHAKRAVARTY, Mark A. RUBIN